Search Results - "Pivato, C A"

Outcomes of percutaneous coronary interventions after transcatheter aortic valve replacement by Pivato, C A, Tartaglia, F, Cerrato, E, Nombela, L, Pilgrim, T, Stefanini, G

“…Abstract Background The number of percutaneous coronary interventions (PCI) after transcatheter aortic valve replacement (TAVR) is expected to increase with…”
Get full text

Long-term cardiovascular risk of pre-eclampsia by Pivato, C A, Inversetti, A, Cristodoro, M, Latini, A C, Condorelli, G, Stefanini, G, De Simone, N

“…Abstract Background/introduction Pre-eclampsia is a complication of the second and third trimesters of pregnancy characterized by hypertension and endothelial…”
Get full text

One-month dual antiplatelet therapy following stent implantation in patients with acute coronary syndromes and high bleeding risk by Pivato, C A, Musto, C, Paolucci, L, Testa, L, Pacchioni, A, Briguori, C, Esposito, G, Lucisano, L, De Luca, L, Latini, A C, Regazzoli, D, Sardella, G, Indolfi, C, Condorelli, G, Stefanini, G G

“…Abstract Background/introduction There is a paucity of data regarding the safety of a one-month dual antiplatelet therapy (DAPT) following percutaneous…”
Get full text

New criteria to identify patients at higher risk for cardiovascular complications after percutaneous coronary intervention by Brener, S J, Spirito, A, Sharma, A, Cao, D, Sartori, S, Zhang, Z, Nicolas, J, Pivato, C A, Cohen, R, Baber, U, Sweeny, J, Sharma, S K, Dangas, G, Kini, A, Mehran, R

“…Abstract A universal definition to identify patients at higher risk of complications after percutaneous coronary intervention (PCI) is lacking. We aimed to…”
Get full text

Prasugrel or clopidogrel in patients with acute coronary syndromes at high thrombotic risk: results from the PROMETHEUS study by Chiarito, M, Cao, D, Zhongjie, Z, Sartori, S, Nicolas, J, Nardin, M, Pivato, C A, Tavenier, A, Rao, S V, Henry, T D, Pocock, S, Dangas, G, Baber, U, Kini, A, Mehran, R

“…Abstract Background Potent P2Y12 inhibitors are recommended on top of aspirin in patients presenting with acute coronary syndrome (ACS). However, guideline…”
Get full text

Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with ACS: a meta-analysis by Tavenier, A H, Chiarito, M, Cao, D, Pivato, C A, Nicolas, J, Nardin, M, Sartori, S, Baber, U, Angiolillo, D J, Capodanno, D, Kini, A S, Sharma, S K, Dangas, G, Mehran, R

“…Abstract Background Dual antiplatelet therapy (DAPT) with a potent P2Y12 inhibitor is recommended in patients with acute coronary syndrome (ACS) and should be…”
Get full text